Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and design-Reference-Cited by-同舟云学术

Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and design

Published:2017-03-23 Issue:3 Volume:31 Page:258-264
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Grenet Guillaume¹²³^ORCID,Lajoinie Audrey⁴,Ribault Shams²,Nguyen Gia Bao²,Linet Thomas²,Metge Augustin²,Cornu Catherine¹²⁴⁵,Cucherat Michel⁵,Moulin Philippe³⁶,Gueyffier François¹²⁴⁵

Affiliation:

1. Hospices Civils de Lyon; Service de Pharmacologie Clinique et Essais Thérapeutiques; BP8071 69376 Lyon France

2. Université de Lyon, Université Lyon 1; F-69000 Lyon France

3. Hospices Civils de Lyon; Hôpital Louis Pradel, Fédération d'endocrinologie, maladies métaboliques, diabète et nutrition; 69500 Bron France

4. Centre d'Investigation Clinique; INSERM CIC 1407/UMR 5558 CNRS; 69500 Bron France

5. Laboratoire de Biométrie et Biologie Evolutive; Université Lyon 1, CNRS, UMR5558; F-69372 Lyon Cedex 08 France

6. INSERM U1060; Université Lyon 1; 69622 Villeurbanne France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/fcp.12263/fullpdf

Reference29 articles.

1. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials;Boussageon;BMJ,2011

2. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials;Hemmingsen;BMJ,2011

3. Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials;Buehler;Cardiovasc. Ther.,2013

4. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetologia,2012

5. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus;Scirica;N. Engl. J. Med.,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits;Diabetologia;2022-08-04

2. SIS3, a good candidate for the reverse of type 2 diabetes mellitus in mice;Fundamental & Clinical Pharmacology;2020-11-08

3. DPP4 inhibitors and respiratory infection, a systematic review and meta-analysis of the CardioVascular Outcomes Trials conducted before the pandemic and implications for the management of diabetes during COVID-19;2020-07-29

4. GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis;PLOS ONE;2019-06-25